This event will discuss emerging research relating to the physiology, psychology and pharmacology of
pain, and its assessment and management.
This event has CPD accreditation
www.lifescienceevents.com/pain2016
#PainESC
3 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Contents
Day 1: Pathophysiology of Pain............................................................................................................... 5
First Session ............................................................................................................................................ 5
Euroscicon Welcome ............................................................................................................................... 5
Introduction by the chair ........................................................................................................................ 5
Where is pain in the brain? ..................................................................................................................... 5
Oral Presentation .................................................................................................................................... 5
The roles of Clathrin Heavy Chain-22 in human pain and touch development ...................................... 5
Q and A .................................................................................................................................................... 5
Oral Presentation .................................................................................................................................... 5
Physical pain threshold and tolerance in self-harm: methodological challenges and future directions 5
Day 1: Pathophysiology of Pain............................................................................................................... 6
Second Session ........................................................................................................................................ 6
Euroscicon Welcome ............................................................................................................................... 6
Introduction by the chair ........................................................................................................................ 6
Talk title to be confirmed ........................................................................................................................ 6
Talk title to be confirmed ........................................................................................................................ 6
Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis .................................................... 6
Oral Presentation .................................................................................................................................... 6
Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain ............. 6
Central GABA-C receptors and anti-nociception .................................................................................... 6
Day 2: Pain Assessment & Diagnosis ...................................................................................................... 7
First Session ............................................................................................................................................ 7
Euroscicon Welcome ............................................................................................................................... 7
Introduction by the chair ........................................................................................................................ 7
Talk title to be confirmed ........................................................................................................................ 7
The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained
and formidable pain category ................................................................................................................. 7
Oral Presentation .................................................................................................................................... 7
Talk title to be confirmed ........................................................................................................................ 7
Brain electrophysiological representation of multidimensional subjective experience of pain during
noxious laser heat stimulation ................................................................................................................ 7
Day 2: Pain Assessment & Diagnosis ...................................................................................................... 8
Second Session ........................................................................................................................................ 8
4 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Euroscicon Welcome ............................................................................................................................... 8
Introduction by the chair ........................................................................................................................ 8
Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms ...................... 8
Talk title to be confirmed ........................................................................................................................ 8
Oral Presentation .................................................................................................................................... 8
Behavioural pain assessment tool development and the development and initial testing of a meta
tool .......................................................................................................................................................... 8
Conceptual framework of pain in persons with mild traumatic brain injury/concussion ...................... 8
Q and A .................................................................................................................................................... 8
Day 3: Pain Management ........................................................................................................................ 9
First Session ............................................................................................................................................ 9
Euroscicon Welcome ............................................................................................................................... 9
Introduction by the chair ........................................................................................................................ 9
What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative
emotional behaviour, and postoperative pain? ..................................................................................... 9
Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients .............................................. 9
Talk tittle to be confirmed ...................................................................................................................... 9
Oral Presentation .................................................................................................................................... 9
Talk title to be confirmed ........................................................................................................................ 9
The impact of baroreflex sensitivity for the treatment of chronic pain. ................................................ 9
Day 3: Pain Management ...................................................................................................................... 10
Second Session ...................................................................................................................................... 10
Euroscicon Welcome ............................................................................................................................. 10
Introduction by the chair ...................................................................................................................... 10
Talk title to be confirmed ...................................................................................................................... 10
Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor 10
Oral Presentation .................................................................................................................................. 10
Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without
the Development of Addiction and Other Toxicities ............................................................................ 10
Adapting the cancer pain management paradigm to non-cancer pain and survivorship .................... 10
5 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 1: Pathophysiology of Pain
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair
Where is pain in the brain? Q and A
Professor Emeritus Amos D Korczyn, Tel Aviv University, Ramat, Israel
08:45 04:45 17:45 Oral Presentation Speaker to be confirmed
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Disconnecting pain - neurosurgical treatments for intractable oncological pain Q and A
Dr. Ido Strauss, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
10:00 06:00 19:00 The roles of Clathrin Heavy Chain-22 in human pain and touch development Q and A
Dr. Mike Nahorski, University of Cambridge, Cambridge, United Kingdom
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:15 07:15 20:15 Gonadal Hormones and Pain Q and A
Professor Anna Maria Aloisi, Università degli Studi di Siena, Siena, Italy
11:45 07:45 20:45 Physical pain threshold and tolerance in self-harm: methodological challenges and future directions Q and A
Dr. Olivia J. Kirtley, University of Glasgow, Glasgow, United Kingdom
12:15 08:15 21:15 Closing remarks, End of Early Session Closing remarks, End of Early Session
6 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 1: Pathophysiology of Pain
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair
Talk title to be confirmed Q and A
Dr. Luana Colloca, University of Maryland School of Nursing University of Maryland School of Medicine, Baltimore, United States
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr. Yang D.Teng, Harvard Medical School, Boston, United States
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Gentian Violet: A Potential Treatment For Cutaneous Leishmaniasis Q and A
Dr Marc Karam, University of Balamand, Biology Department, Kourah, Lebanon
16:00 12:00 01:00 Decreasing Tumor Necrosis Factor-alpha Solely in the Brain for Treatment of Neuropathic Pain Q and A
Professor Tracey A. Ignatowski, University at Buffalo, Buffalo, United States
16:30 12:30 01:30 Oral Presentation Speaker to be confirmed
16:45 12:45 01:45 Session Break Poster Viewing
17:15 13:15 02:15 Targeting mRNA translation regulation to alleviate nociceptor plasticity driving chronic pain Q and A
Dr. Theodore Price, University of Texas at Dallas, Richardson, United States
17:45 13:45 02:45 Inpatient headache managament for migraines and chronic daily headaches Q and A
Dr. Priyanka Chaudhry, Baylor Comprehensive Headache Center, Dallas, United States
18:15 14:15 03:15 Central GABA-C receptors and anti-nociception Q and A
Professor Sastry Bhagavatula, The University of British Columbia, Vancouver, Canada
18:45 14:45 03:45 Closing remarks, End of Late Session
7 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 2: Pain Assessment & Diagnosis
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia
08:00 04:00 17:00 Talk title to be confirmed Q and A
Dr. Ramakrishnan Mani, University of Otago, Dunedin, New Zealand
08:30 04:30 17:30 Where does the pain come from in osteoarthritis? Q and A
Professor Graeme Jones, University of Tasmania, Hobart TAS, Australia
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Thinking outside of the joint: The role of the brain in osteoarthritic pain and stiffness Q and A
Dr. Tasha Stanton, The University of South Australia, School of Health Science, Adelaide, Australia
10:00 06:00 19:00 The use of animal models to elucidate the pathophysiology of “dysfunctional pain”, an unexplained and formidable pain category Q and A
Dr. Yukinori Nagakura, Aomori University, Aomori, Japan
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:15 07:15 20:15 Talk title to be confirmed Q and A
Dr. Mary Ann Muckaden, Tata Memorial Centre, Mumbai, India
11:45 07:45 20:45 Brain electrophysiological representation of multidimensional subjective experience of pain during noxious laser heat stimulation Q and A
Dr. Andrej Stancak, University of Liverpool, Liverpool, United Kingdom
12:15 08:15 21:15 Closing remarks, End of Early Session
8 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 2: Pain Assessment & Diagnosis
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair Dr Cliff Richardson, University of Manchester, Manchester, United Kingdom
14:00 10:00 23:00 Phantom limb pain in lower limb amputees: a discussion of the potential mechanisms
Dr. Cliff Richardson, University of Manchester, Manchester, United Kingdom
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr Rhiannon Worrall, Burton Hospital, Staffordshire, United Kingdom
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Oral Presentation Speaker to be confirmed
16:00 12:00 01:00 Behavioural pain assessment tool development and the development and initial testing of a meta tool Q and A
Dr. Julie Gregory, University of Manchester, Manchester, United Kingdom
16:30 12:30 01:30 Conceptual framework of pain in persons with mild traumatic brain injury/concussion Q and A
Dr. Tatyana Mollayeva, University of Toronto, Toronto, Canada
17:00 13:00 02:00 Closing remarks, End of Late Session
9 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 3: Pain Management
London GMT
New York EDT
Tokyo JST
First Session
07:15 03:15 16:15 Session online
Speaker practice session Poster Viewing
07:45 03:45 16:45 Euroscicon Welcome Euroscicon Host
07:50 03:50 16:50 Introduction by the chair Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary
08:00 04:00 17:00 What are the effects of therapeutic play intervention on children’s perioperative anxiety, negative emotional behaviour, and postoperative pain? Q and A
Dr. He Hong-Gu, National University of Singapore, Singapore
08:30 04:30 17:30 Novel morphine analogue 14-O-methylmorphine with high mu opioid receptor agonist efficacy, selectivity and affinity Q and A
Dr Ferenc Zádor, Hungarian Academy of Sciences, Szeged, Hungary
09:00 05:00 18:00 Session break Poster Viewing
09:30 05:30 18:30 Morphine - P2Y12 inhibitors, a drug-drug interaction in STEMI patients Q and A
Professor Jacek Kubica, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland
10:00 06:00 19:00 Talk tittle to be confirmed Q and A
Speaker to be confirmed
10:30 06:30 19:30 Oral Presentation Speaker to be confirmed
10:45 06:45 19:45 Session Break Poster Viewing
11:45 07:45 20:45 Talk title to be confirmed Q and A
Dr. Eleni Besi, Eastman Dental Hospital, UCLH NHS Foundation Trust, United Kingdom
12:15 08:15 21:15 The impact of baroreflex sensitivity for the treatment of chronic pain.
Dr. Kati Thieme, Philipps-University of Marburg, Marburg, Germany
12:45 08:45 21:45 Closing remarks, End of Early Session
10 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
Day 3: Pain Management
London GMT
New York EDT
Tokyo JST
Second Session
13:15 09:15 22:15 Session online Speaker practice session Poster Viewing
13:45 09:45 22:45 Euroscicon Welcome Euroscicon Host
13:50 09:50 22:50 Introduction by the chair Chair to be confirmed
14:00 10:00 23:00 Role of 6TM-mOR and GPCR heterodimerization in opioid induced hyperalgesia Q and A
Dr. Marino Convertino, University of North Carolina, United States
14:30 10:30 23:30 Talk title to be confirmed Q and A
Dr. Felipe Fregni, Harvard Medical School, United States
15:00 11:00 00:00 Session break Poster Viewing
15:30 11:30 00:30 Chronic Pain Among Opioid Addiction Patients: Identifying and Managing an Important Risk Factor Q and A
Dr. Zainab Samaan, McMaster University, Hamilton, Canada
16:00 12:00 01:00 Chronic Pain and Addiction: the Crossroads
Q and A
Dr. Peter Przekop, Loma Linda University, Loma Linda, United States
16:30 12:30 01:30 Oral Presentation Speaker to be confirmed
16:45 12:45 01:45 Session Break Poster Viewing
17:15 13:15 02:15 Design of Novel Multivalent Ligands for the Treatment of Prolonged and Neuropathic Pain Without the Development of Addiction and Other Toxicities Q and A
Dr. Victor J. Hruby, Regents Professor, Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA
17:45 13:45 02:45 Adapting the cancer pain management paradigm to non-cancer pain and survivorship Q and A
Dr. Pippa Hawley, BC Cancer Agency, Vancouver, Canada
18:15 14:15 03:15 Closing remarks, End of Late Session
11 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
12 EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address: Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts.
EN5 5SU, UK. Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK
MEDIA SPONSORS
Missing Speakers
It is unfortunate that occasionally a speaker cannot attend. Whilst we do everything possible to ensure that our speakers are present at the event we apologise in advance if you were at a session where a speaker could not attend. We always try to keep our agendas as up to date as possible, however if a speaker cancels the night before an event or on the day, there is little we can do to rectify this.